Patrizia Giannatempo

Patrizia Giannatempo

UNVERIFIED PROFILE

Are you Patrizia Giannatempo?   Register this Author

Register author
Patrizia Giannatempo

Patrizia Giannatempo

Publications by authors named "Patrizia Giannatempo"

Are you Patrizia Giannatempo?   Register this Author

66Publications

2379Reads

44Profile Views

Epidemiology and unmet needs of bladder cancer in Italy: a critical review.

Minerva Urol Nefrol 2019 Nov 4. Epub 2019 Nov 4.

Janssen Cilag SpA, Cologno Monzese, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0393-2249.19.03498-2DOI Listing
November 2019

Erdafitinib for the treatment of urothelial cancer.

Expert Rev Anticancer Ther 2019 Oct 4;19(10):835-846. Epub 2019 Oct 4.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1671190DOI Listing
October 2019

Comparison of Fibroblast Growth-factor Receptor Gene Alterations at the DNA versus Messenger RNA Level in Advanced Urothelial Cancer: Insights for Clinical Research.

Eur Urol Focus 2019 Jul 30;5(4):689-692. Epub 2017 Aug 30.

Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2017.08.002DOI Listing
July 2019

Palliative treatment of germ cell cancer.

Cancer Treat Rev 2018 Dec 22;71:102-107. Epub 2018 Oct 22.

Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, CH-3031 Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183016
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.10.007DOI Listing
December 2018

Nivolumab and its use in the second-line treatment of metastatic urothelial cancer.

Future Oncol 2018 Nov 21;14(26):2683-2690. Epub 2018 Jun 21.

Deptartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0735DOI Listing
November 2018

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.

J Clin Oncol 2018 Oct 20:JCO1801148. Epub 2018 Oct 20.

Andrea Necchi, Andrea Anichini, Daniele Raggi, Simona Massa, Maurizio Colecchia, Patrizia Giannatempo, Roberta Mortarini, Elena Farè, Francesco Monopoli, Antonella Messina, Roberto Salvioni, and Luigi Mariani, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori; Alberto Briganti, Roberta Lucianò, Marco Bianchi, Renzo Colombo, Andrea Gallina, Andrea Salonia, and Francesco Montorsi, Vita Salute San Raffaele University and Urological Research Institute, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Hospital, Milan, Italy; Siraj M. Ali, Russell Madison, Jeffrey S. Ross, and Jon H. Chung, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Upstate Medical University, Syracuse, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.01148
Publisher Site
http://dx.doi.org/10.1200/JCO.18.01148DOI Listing
October 2018

Immunotherapy for metastatic urothelial carcinoma: status quo and the future.

Curr Opin Urol 2018 Jan;28(1):1-7

Cochin Hospital, Assistance-Publique Hôpitaux de Paris, Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000457DOI Listing
January 2018

Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib.

Invest New Drugs 2017 08 3;35(4):524-528. Epub 2017 Feb 3.

Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo 42, I-20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-017-0440-5DOI Listing
August 2017

A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.

Clin Genitourin Cancer 2017 04 8;15(2):306-312.e3. Epub 2016 Aug 8.

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.07.022DOI Listing
April 2017

Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors.

Am J Clin Oncol 2017 02;40(1):60-65

*Department of Medical Oncology †Clinical Epidemiology and Trials Organization Unit ‡Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori §Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/COC.0000000000000113DOI Listing
February 2017

Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma.

Bladder Cancer 2016 Oct 27;2(4):395-403. Epub 2016 Oct 27.

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-160069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181661PMC
October 2016

Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed.

Clin Genitourin Cancer 2016 Jun 11;14(3):231-6. Epub 2015 Aug 11.

Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.08.001DOI Listing
June 2016

Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy.

Tumori 2015 Nov-Dec;101(6):692-6. Epub 2015 Jun 12.

Supportive Care in Cancer Unit, Department of Hematology and Pediatric Onco-Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000351DOI Listing
March 2016

The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?

Clin Genitourin Cancer 2016 Feb 6;14(1):1-4. Epub 2015 Aug 6.

Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.07.021DOI Listing
February 2016

Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.

Clin Genitourin Cancer 2016 Feb 7;14(1):e81-90. Epub 2015 Aug 7.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.07.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003615PMC
February 2016

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group.

J Clin Oncol 2016 Feb 12;34(4):345-51. Epub 2015 Oct 12.

Darren R. Feldman, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY; Anja Lorch, University Hospital Düsseldorf, Düsseldorf; Carsten Bokemeyer, University Hospital Eppendorf, Hamburg, Germany; Andrew Kramar, Centre Oscar Lambret, Lille; Aude Flechon and Helen Boyle, Centre Léon Bérard, Lyon, France; Costantine Albany and Lawrence H. Einhorn, Indiana University, Bloomington, IN; Patrizia Giannatempo and Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milano; Teodoro Sava, Azienda Ospedaliera Universitaria Integrata di Verona, Verona; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto di Ricovero e Cura a Carattere Scientifico, Meldola, Italy; Peter Chung, Princess Margaret Cancer Centre, University of Toronto, Toronto; Eric William Winquist, London Health Sciences Center, London, Ontario, Canada; Robert A. Huddart, Royal Marsden Hospital; Thomas Powles, St Bartholomew's Hospital, London, United Kingdom; Alexey Tryakin, Blokhin's Russian Cancer Research Center, Moscow, Russia; Jorge Aparicio, University Hospital Le Fe, Valencia, Spain; Christopher J. Sweeney, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Gabriella Cohn Cedermark, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; and Jörg Beyer, UniversitätsSpital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.7000
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.7000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070579PMC
February 2016

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma.

Ther Adv Urol 2015 Jun;7(3):152-61

Department of Medical Oncology, Unit 1 Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287215574457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485412PMC
June 2015

Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.

Clin Genitourin Cancer 2014 Jun 13;12(3):196-202.e1. Epub 2013 Nov 13.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.11.021DOI Listing
June 2014

[Funcion sparing surgery in uro-oncology: germ cell tumors of the testis].

Urologia 2012 Dec 30;79 Suppl 19:15-9. Epub 2012 Dec 30.

UOC Urologia, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/RU.2012.9736DOI Listing
December 2012

New directions for biologic targets in urothelial carcinoma--letter.

Mol Cancer Ther 2012 Oct 2;11(10):2306; author reply 2307. Epub 2012 Oct 2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0515DOI Listing
October 2012